X-linked spinal and bulbar muscular atrophy (SBMA; Kennedy's disease) is a polyglutamine disease in which affected males suffer progressive motor neuron degeneration accompanied by signs of androgen insensitivity, such as gynecomastia and reduced fertility.
INTRODUCTION
Although polyQ expansion mutations produce a dominant gain-of-function toxicity, gain-of-function and loss-of-function mechanisms are not mutually exclusive in these diseases.
Indeed, there is considerable evidence for a pathogenic role of diminished normal function of disease proteins containing polyQ tract expansions. In one study, postnatal elimination of huntingtin protein expression yielded striatal degeneration in HD conditional knock-out mice (21) . In another murine model, the HD YAC128 mouse, absence of endogenous huntingtin expression accentuated HD neuropathology (22, 23) . Various in vitro studies have also found that cells with depressed levels of huntingtin expression are more susceptible to polyQ toxicity (24, 25). As most polyQ disease proteins are widely expressed throughout the neuraxis but only produce degeneration in select regions of the central nervous system, partial loss of disease protein function could render particular neurons exquisitely sensitive to the toxic gain-offunction effects that a polyQ expansion imparts to the disease protein. Although a mechanistic explanation for how loss-of-function of a polyQ protein contributes to polyQ disease pathogenesis is lacking, a number of recent studies have further underscored the importance of polyQ disease protein normal function (26-31). In the case of SBMA, whether partial loss of AR function contributes to the motor neuron degeneration remains unclear.
To investigate whether normal AR function plays a role in SBMA neurodegeneration, we employed a highly representative SBMA mouse model (i.e. the AR100 mouse) in which the human AR gene carrying 100 CAG repeats is expressed under proper temporal and spatial regulation within a 450 kb DNA fragment contained in a yeast artificial chromosome (YAC) (32). The AR100 mouse displays a late-onset, neuromuscular, gender-specific phenotype characterized by neurogenic atrophy. To evaluate the contribution of normal AR function to and AR100Tfm mice express the same amount of polyQ-expanded AR; however, AR100Tfm mice exhibit earlier onset of weight loss, kyphosis, hindlimb atrophy, weakness, and neurodegeneration compared to AR100 mice. Interestingly, the AR null background not only accelerated the neuromuscular phenotype of AR100 transgenic mice, but also uncovered androgen insensitivity in sexual organs and in the spinal cord. These results support a role for the loss of wild-type AR protein function in SBMA disease pathogenesis.
RESULTS

AR100Tfm mice develop an accelerated neuromuscular phenotype
To study the role of normal AR function in the AR100 YAC transgenic mouse model of SBMA (32), we obtained female mice heterozygous for the Testicular feminization (Tfm) mutation and crossed these female Tfm carriers with male AR100 and AR20 transgenic mice. The Tfm mutation is a spontaneous single base-pair frameshift mutation in the first exon of the murine AR gene that eliminates the expression of endogenous Ar protein (33). Tfm mice are viable, but are effectively Ar null and therefore recapitulate the phenotype of human testicular feminization syndrome (15, 33) . As the Tfm mice are maintained on a C57BL/6J background, and our AR20
and AR100 lines had been backcrossed onto the C57BL/6J background for >12 generations, a confounding effect of strain background differences did not complicate this breeding scheme.
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All offspring obtained from female Tfm x male AR100 (or AR20) matings were genotyped for the human AR YAC transgene, the Tfm mutation, and the Y chromosome.
To determine the effect of endogenous androgen receptor function upon the SBMA phenotype,
we compared the behavioral phenotypes of AR100, AR100Tfm, AR20, AR20Tfm, nontransgenic and Tfm male mice obtained from crossing female Tfm mice with male AR100 or AR20 transgenic mice. By 8 months of age, AR100Tfm mice were already smaller and lighter than their AR100 littermates (Fig. 1A) . During the course of their lives, both AR100 and AR100Tfm mice displayed a failure to gain weight and even lost weight compared to controls; however, the AR100Tfm weight loss was significantly worse than the AR100 weight loss. A distinguishing feature of the AR100 SBMA mouse model is kyphosis (i.e. curvature of the spine) due to proximal muscle weakness (32). With disease progression at 11 months of age, AR100 mice are visibly kyphotic and smaller than normal (Fig. 1B) . AR100Tfm mice at 11 months of age, however, always appeared the smallest and most kyphotic of the Tfm x AR100 progeny (Fig. 1B) . To compare the phenotypic severity of littermate progeny obtained from these crosses, we developed a phenotype rating scale (Table 1) . When a blinded observer rated the phenotypic severity of Tfm x AR100 and Tfm x AR20 progeny at 7 and 10 months of age using this scale, a worsening of the SBMA disease phenotype in AR100Tfm mice became apparent ( Fig. C-D) . To further validate and quantify the differences in phenotypic severity between AR100 and AR100Tfm mice, we performed grip strength analysis on age-matched littermates.
Although AR100 mice did not display significant impairments in grip strength at 10 months of age in comparison to AR20 mice, AR100Tfm mice did exhibit significant weakness (Fig. 1E ).
By 17 months of age, AR100 mice were significantly weaker than age-matched AR20 mice in the grip strength paradigm; however, AR100Tfm were by far the weakest cohort tested (Fig. 1F ).
Although AR100Tfm mice display muscle atrophy reminiscent of SBMA, confirmation of neurogenic muscle atrophy requires the use of special histopathology stains. To confirm the existence of a motor neuronopathy and compare its severity among the Tfm x AR100 progeny, we combined hematoxylin and eosin (H&E) staining of quadriceps muscle sections with immunostaining for neural cell adhesion molecule (NCAM), a protein known to be up-regulated during muscle renervation (34). At 6.5 months of age, AR100 mice display only modest muscle pathology with limited fiber size variation and some replacement of muscle by fibrous tissue and fat, in comparison to non-transgenic and Tfm controls ( Fig. 2A-C) . Muscle sections from AR100Tfm mice, however, display significant variation in fiber size with considerable connective tissue replacement and fat infiltration (Fig. 2D ). NCAM staining correspondingly revealed only occasional positive muscle fibers in AR100 mice, but detected frequent positive muscle fibers in AR100Tfm mice ( Fig. 2E-H ). These findings suggest that absence of endogenous AR protein results in more rapidly progressive muscle atrophy due to denervation in SBMA mice. Given these obvious differences in muscle histopathology, basic dye staining of lumbar cord sections from non-transgenic, Tfm, AR100, and AR100Tfm indicated a trend toward increased motor neuron drop-out in the AR100Tfm sections ( Fig. 2I-L) ; however, counting of neurons from cord sections did not yield a significant difference in motor neuron number (data not shown). This was not surprising since the production of a neurological phenotype in mouse models for the polyQ repeat diseases is not clearly associated with neuron cell death (35) .
Transgenic expression of AR100 protein does not rescue the Tfm phenotype in SBMA mice
SBMA patients display signs of androgen insensitivity (6, 7) . The AR100 YAC mouse model of SBMA does not display androgen insensitivity signs since the mutant human AR transgene is expressed in the presence of the normal endogenous mouse AR gene (32). After crossing male AR20 and AR100 transgenic mice with female Tfm carriers, we derived AR20Tfm and AR100Tfm mice, and evaluated them for signs of an androgen insensitivity phenotype. We first examined the distance between the anus and genitals of mice (i.e. the anogenital distance {AGD}), as AGD is a reliable measure of external masculinization in mice (36, 37) . Normal male mice have an AGD at least 50% greater than that of female mice or androgen-insensitive Tfm mice (Fig. 3A-B ). Visual inspection of external genitalia of AR20Tfm and AR100Tfm mice revealed that neither human AR20 protein nor AR100 protein completely restored the AGD to normal male values ( Fig. 3C-D) . Although the AR20 (line C9B) transgene and AR100 (line C25) transgene are expressed equivalently at roughly endogenous levels (32), AGD in the AR20Tfm mice was roughly twice that of AGD in the AR100Tfm mice, indicating that the AR20 protein was better able to rescue the female-like anogenital appearance produced by the Tfm mutation in comparison to AR100 protein (Fig. 3E) reflects the bioactive testosterone fraction. In AIS patients, testosterone and LH levels are often elevated in proportion to the degree of insensitivity (17) . We therefore obtained serum samples from adult non-transgenic, Tfm, AR20, AR20Tfm, AR100 and AR100Tfm mice, and measured their levels of LH, total testosterone, and FT. Expression of the AR100 protein was associated with increased total testosterone and FT levels, and comparison of AR100Tfm mice with AR20Tfm mice revealed that total testosterone and FT levels were ~ 3 -5x greater in the AR100Tfm mice in comparison to AR20Tfm mice ( Fig. 3F-G ). This pronounced difference was also reflected in LH, as AR100Tfm mice displayed LH levels that were ~ 8x greater than LH levels in AR20Tfm mice (Fig. 3H) . Levels of total testosterone and LH in AR20Tfm mice were comparable to those measured in AR20 and non-transgenic mice, while Tfm mice displayed very low testosterone levels and elevated LH ( Fig. 3F-H ). These findings indicated that the AR100 protein was unable to adequately perform its expected endocrine end organ functions in the AR100Tfm mice. As a final measure of AR function, we perfused AR transgenic mice of various genetic constitutions, dissected out their testes, and compared testes weights, as testicular atrophy is also a hallmark of androgen insensitivity in SBMA. Surprisingly, we noted a significant reduction in testes weight in AR100 mice when compared to AR20 mice (Supplementary Figure 1) , which, when taken together with the increased FT levels in AR100 mice ( Fig. 3F) Both AR20Tfm and AR100Tfm testes lacked spermatids and displayed failure of germ cell progression in their remnant seminiferous tubules ( Fig. 4C-D) . Although both AR20Tfm and AR100Tfm testes were markedly abnormal, AR20Tfm testes better approximated the expected circumferential layering of germ cells, whereas AR100Tfm testes were utterly disorganized and contained degenerating spermatocytes marked by regions of dense chromatin and frequent vacuolization. Thus, although neither the AR20 nor the AR100 protein could rescue the testes abnormalities in mice lacking functional endogenous AR, AR100Tfm testes always appeared worse than AR20Tfm testes. We also evaluated testes sections from AR100 transgenic mice, and noted that their seminiferous tubules were relatively normal in appearance and contained numerous extruded spermatids, consistent with their fertile status ( Fig 4E) .
How does impaired AR100 protein function worsen SBMA neurodegeneration?
at 
Effect of polyQ length expansion upon AR transactivation competence
Endocrine, reproductive, and neuroanatomical characterization of the AR100Tfm mice strongly supports the view that polyQ tract expansion in AR decreases its normal function of liganddependent transcription activation. To test this hypothesis, we obtained M12 cells, a line of cells derived from a primary prostate carcinoma that does not express AR (47) . We then co-expressed human AR cDNA's of different polyQ lengths (n = 20, 66, 112 and 250), a triple probasin ARresponse element (ARE) promoter reporter construct, and Renilla luciferase, and measured AR transactivation competence. PolyQ tract expansion produced significant repression of AREdriven transactivation in a polyQ length dependent manner (Fig. 7) . This reduction could not be attributed to differences in AR protein translation, as we documented comparable expression of AR20, AR66, AR112 and AR250 protein on Western blots (data not shown), and also normalized promoter activity to protein levels (Fig. 7) .
DISCUSSION
While the paradigm of polyQ expansion as a toxic gain-of-function mutation is supported by numerous investigations (11, 19, 20) , the question of whether loss or alteration of a polyQ disease protein's normal function might concomitantly contribute to polyQ neurodegeneration has arisen. In HD, there is strong evidence supporting a role for loss or alteration of normal huntingtin protein function in disease pathogenesis -postnatal elimination of huntingtin gene expression in the forebrain of mice appears to result in striatal degeneration (21 and endocrine -reproductive functions could not be attributed to strain background effects, as the female Tfm mice were on a pure C57BL/6J background and the AR transgenic mice were incipient C57BL/6J congenic mice at the time of the cross-breeding.
In SBMA, affected males typically do not present with neuromuscular disease until the fourth decade of life; however, it is not uncommon for SBMA patients to be recognized for breast enlargement after puberty or to present to endocrinologists due to concerns over reduced fertility prior to the onset of their neurological disease. Although the androgen insensitivity phenotype in SBMA is highly variable, SBMA patients always appear male from birth and there has never been any report of SBMA patients who are incompletely masculinized or have ambiguous genitalia. In the AR100Tfm mice, we observed a dramatic AIS phenotype, as male mice displayed AGD sizes that were more consistent with the appearance of females, had incompletely descended testes, and were infertile. This severe androgen insensitivity In addition to finding evidence for impaired AR function as a potential contributor to spinal cord motor neuron degeneration in AR100Tfm mice, we noted that spinal cord motor neurons in AR100Tfm male mice more frequently accumulate the mutant AR protein in their nuclei in comparison to AR100 male mice. As AR100Tfm mice display markedly increased levels of androgen, we attributed this increased nuclear localization of mutant AR in motor neuron nuclei to the presence of higher circulating levels of androgen in their bloodstreams. Indeed, both human SBMA females and female SBMA transgenic mice do not develop a pronounced motor neuronopathy, as they do not produce sufficiently high levels of testosterone (18, 32, 42) . Further studies will be needed to dissect the interplay of these pathways, but resolution of this problem will be crucial for therapy development, since a number of promising therapeutic options rely upon RNAi knock-down of mutant gene expression (71) . Unless such approaches can discriminate between the mutant allele and the normal allele, non-specific knock-down could 
Materials and Methods
Mouse genetics and expression analysis
Production and characterization of the AR YAC CAG20 (AR20) and AR YAC CAG100 
Behavioral analysis and physical examination
A blinded examiner performed the following phenotype assessment. Mice were weighed, rated for kyphosis, analyzed for quadriceps muscle thickness by palpation, observed during ambulation, and judged for activity levels. Using these metrics, a phenotype severity score was assigned using a pre-determined rating scale (see Table 1 ). We designed a grip strength testing apparatus by attaching an Accuforce dynamometer (Ametek; Largo, FL) to an 18" high plastic stand. Each animal was lowered by the tail onto a wire grid to measure combined forepawhindlimb strength force. Each animal was tested five times in succession, and the highest grip strength was recorded as the grip strength for that animal. For determination of anogenital distance (AGD), the distance between the border of the anus and genitals was measured to the nearest centimeter with calipers by a blinded examiner. Cages of mice with the genotypes of interest were selected randomly for all behavioral assays and physical examinations.
Histology and immunohistochemistry
After anesthetization, the mice were perfused transcardially with heparinized saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer (ph 7.4). In some cases, the spinal cord was immediately removed and processed as described previously (32). In other cases, spinal columns were removed and immersed in 4% paraformaldehyde (PFA) and then coded for blind analysis. Sections were processed for Nissl substance using cresyl violet staining. Slides were then dehydrated in graded ethanol, cleared in citra-solv, and cover-slipped. For double-blind analysis, the slides were coded, randomized, and examined under light microscopy by an individual unaware of coding. Motor neurons of the SNB, DLN and VMP were identified based upon size and location, and analyzed under light microscopy, as previously described (74, 75) . Motor neurons from each pool were counted and 50% of neurons (all unilaterally) were digitized under a 40x objective using a Leica DMB500 5.0 Mpix digital camera connected to a Leica DM5000b microscope. Digitized images of motor neurons were analyzed for somal area using the NIH Image-J program. For analysis of testes, mice were perfused as described above, and then testes were dissected out and weighed. Each testis was embedded in a paraffin block, serially sectioned (5 µm thickness), stained with hematoxylin and eosin, and examined. Muscle histopathology studies were performed as previously described (32). Confocal microscopy of frozen spinal cord transverse sections was performed as previously described (76 
Measurement of hormone levels
Blood was collected from 10 month-old male mice by retro-orbital collection with heparinized capillary tubes (Chase Scientific; Rockwood, TN). Whole blood was centrifuged at 2,000 g x 10 min in a 4°C microfuge (Eppendorf Centrifuge 5417R) to collect serum for analysis. Each Lipofectamine reagent (Invitrogen) in serum-free media. After a 3 hr exposure to the lipofectamine/DNA/plus mixture, the medium was supplemented with 1% charcoal-stripped FBS and incubated for 24 hrs, after which the transfection medium was removed and DHT at a concentration of 10 nM was added for 24 hours. Luciferase activity was determined using the Luciferase Assay System (Promega) according to the manufacturer's protocol.
Statistical analysis
All statistical analysis was performed using SPSS 12.02 for Windows (SPSS, Chicago, IL), GB- (C) AR100Tfm mice display a more severe phenotype at 7 months of age. Sets of control and AR transgenic mice (n = 5 -8 / group) were assigned a phenotype severity score (see Table 1) by a blinded observer. Although AR100 mice do not display signs of disease, 80% of the AR100Tfm cohort were scored as abnormal, indicating more severe disease (p < .05 by MannWhitney U test).
at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from (D) AR100Tfm mice display a more severe phenotype at 10 months of age. Sets of control and AR transgenic mice (n = 5 -8 / group) were assigned a phenotype severity score (see Table 1) by a blinded observer. All but one of the AR100Tfm mice were rated as abnormal, and the severity of disease in the AR100Tfm group significantly exceeded phenotypic severity in the other cohorts, including the AR100 group (p < .05 by Mann-Whitney U test). Multiple regression analysis revealed that both endogenous AR status and glutamine tract length are significant independent factors in determining SNB motor neuron number (p < 0.01). Luciferase activity was normalized to protein expression by calculating the ratio of luciferase activity to the intensity of AR protein measured from an aliquot of transfected cells by Western blot analysis. Ratio values were then normalized to the AR20 mean result that was arbitrarily set to 1.0. Promoter activation by AR20 was significantly greater than promoter activation by AR66, whose transactivation significantly exceeded that of AR112 or AR250 (p < 0.05 by ANOVA; post-hoc testing significant at p < 0.05 for all comparisons, except AR112 vs. AR250).
All transfections were performed in duplicate, and measurements were done in triplicate. Error bars correspond to SEM. Sequestration of AR protein into aggregates was excluded by examining the stacking portions and wells of immunoblotted protein lysates from transfected M12 cell lines analyzed by Western blot, and noting absence of immunoreactivity. 
